Consistent with inhibiting AR activity, a small molecule inhibitor of AR NTD, EPI-001 (Figure 5) blocks AR-dependent proliferation in human prostate cancer cells that express AR and has no effect on the proliferation of cells that do not express functional AR or do not rely on the AR for growth and survival [66]. This evidence concerns the gene AR and prostate cancer.